See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.

There is typically a year-round demand for the Company's products, however, passenger car and light truck replacement tires, but passenger car("light vehicle") replacement tire sales are generally strongest during the third and fourth quarters of the year. Winter tires are sold principally during the months of JuneMay through November. Operating results for the six month period ended June 30, 20192020 are not necessarily indicative of the results that may be expected for the year ended December 31, 2019.2020.

The Company consolidates into its financial statements the accounts of the Company, all wholly-owned subsidiaries, and any partially-owned subsidiary that the Company has the ability to control. Control generally equates to ownership percentage, whereby investments that are more than 50 percent owned are consolidated and investments in affiliates of 50 percent or less, but greater than 20 percent, are accounted for using the equity method, and investments in affiliates of 20 percent or less are accounted for using the cost method. The Company does not consolidate any entity for which it has a variable interest based solely on power to direct the activities and significant participation in the entity’s expected results that would not otherwise be consolidated based on control through voting interests. Further, the Company’s joint ventures are businesses established and maintained in connection with the Company’s operating strategy. All intercompany transactions and balances have been eliminated.

AtAnti-dilutive shares are excluded from the computation of loss per share for the three and six month periods ended June 30, 20192020, as the inclusion of such items would decrease loss per share. All stock options and 2018, all options to purchase shares of the Company’s commonother stock units outstanding were included in the computation of diluted earnings per share as the options’ exercise prices were less than the average market price of the common shares.

Each change to U.S. GAAP is established by the Financial Accounting Standards Board (“FASB”) in the form of an accounting standards update (“ASU”) to the FASB’s Accounting Standards Codification (“ASC”).

Inventory costs are determined usingThe Company uses the last-in, first-out ("LIFO") method for substantially all U.S. inventories. The current cost of the U.S. inventories under the FIFOfirst-in, first-out ("FIFO") method was $484,351$352,213 and $380,990$365,585 at June 30, 20192020 and December 31, 2018,2019, respectively. These FIFO values have been reduced by approximately $94,865$44,634 and $85,068$87,616 at June 30, 20192020 and December 31, 2018,2019, respectively, to arrive at the LIFO value reported on the Condensed Consolidated Balance Sheets. The Company's remaining inventories have been valued under the FIFO method. All LIFO inventories are valued at the lower of cost or market. All other inventories are stated at the lower of cost or net realizable value.

For the three month period ended June 30, 2019,2020, the Company recorded aan income tax benefit of $882 (effective tax rate of 13.5 percent) compared to an income tax provision for income taxes of $5,851 (effective tax rate of 38.7 percent) compared to $2,267 (effective tax rate of 12.6 percent) for the same period in 2018.2019. For the six month period ended June 30, 2019,2020, the Company recorded aincome tax benefit of $1,542 (effective tax rate of 8.3 percent) compared to an income tax provision for income taxes of $12,186 (effective tax rate of 42.6 percent) compared to $5,718 (effective tax rate of 18.8 percent) for the same period in 2018. 2019.

The 2019Company's 2020 and 20182019 three and six month period (benefit)/provisions for income taxestax are calculated using a forecasted multi-jurisdictional annual effective tax rate to determine a blended annual effective tax rate. The Company is subject to the U.S. federal statutory rate of 21 percent. The effective tax rate for the three month period ended June 30, 2020 differs from the U.S. federal statutory rate primarily due to the lower level and projected mix of earnings in international jurisdictions with differing tax rates, jurisdictions where valuation allowances are recorded, and discrete tax expense of $235. The effective tax rate for the six month period ended June 30, 2020 differs from the U.S. federal statutory rate primarily due to $4,361 of additional unrecognized tax benefit related to the tax deductibility of certain business expenses incurred during the first quarter, the lower level and projected mix of earnings in international jurisdictions with differing tax rates, and jurisdictions where valuation allowances are recorded. The effective tax rate for the three and six month periods ended June 30, 2019 differs from the U.S. federal statutory rate of 21 percent primarily due to net discrete tax expense of $1,968 and $4,385 recorded during the three and six month periods, respectively, as well as due to the projected mix of earnings in international jurisdictions with differing tax rates and jurisdictions where valuation allowances are recorded. The discrete tax items in the second quarter primarily consist of state reserves for additional uncertain tax positions of $4,710 partially offset by expected refunds and deferred tax benefits related to other state filings of $2,958. For the six month period ended June 30, 2019, the discrete items also include 2017 transition tax and unrecognized tax benefits accrued of $1,655 and $670, respectively, as a result of final U.S. federal tax guidance issued during the first quarter pertaining to the one-time mandatory deemed repatriation under the 2017 Tax Act.

The Company continues to maintain valuation allowances pursuant to ASC 740, “Accounting for Income Taxes,” against portions of its U.S. and non-U.S. deferred tax assets at June 30, 20192020 as it cannot assure the future realization of the associated tax benefits prior to their reversal or expiration. In the U.S., the Company has offset a portion of its net operating loss carryforward deferred tax asset relating primarily to a loss carryforward by a valuation allowance of $1,402.$1,378. In addition, the Company has recorded valuation allowances of $23,065 relating$24,459 related to non-U.S. net operating losses and other deferred tax assets for a total valuation allowance of $24,467.$25,837. In conjunction with the Company’s ongoing review of its actual results and anticipated future earnings, the Company will continue to reassess the possibility of releasing all or part of the valuation allowances currently in place when the associated deferred tax assets are deemed to be realizable.

The Company operates in multiple jurisdictions throughout the world. The Company has effectively settled U.S. federal tax examinations for tax years before 20152016 and state and local examinations for tax years before 2013,2012, with limited exceptions.

Furthermore, the Company’s non-U.S. subsidiaries are generally no longer subject to income tax examinations in major foreign taxing jurisdictions for tax years prior to 2015.2014. Certain of the Company's state income tax returns in various jurisdictions are currently under examination and it is possible that these examinations will conclude within the next twelve months. However, it is not possible to estimate net increases or decreases in the Company’s unrecognized tax benefits related to these exams during the next twelve months.

On February 15, 2018,June 27, 2019, the Company amended its revolving credit facility ("Credit Facility") with a consortium of banks that provided up to $400,000 based on available collateral, including an $110,000 letter of credit subfacility, set to expire in February 2023. As of June 27, 2019, the Company amended this Credit Facility with a consortium of several banks that providesto provide up to $700,000 and is set to expire in June 2024. Of this amended borrowing capacity, $200,000 iswas allocated to a Delayed Draw Term Loan A ("Term Loan A"), which is scheduled to be drawn in December 2019, while the remaining $500,000 iswas allocated to the Credit Facility. The Term Loan A funds were drawn in December 2019 and used primarily to pay for the unsecured notes which matured at that time. The Credit Facility stillalso includes thea $110,000 letter of credit sub-facility. The Company may elect, with lender consent, to increase the commitments under the Credit Facility or incur one or more tranches of term loans in an aggregate amount of up to $300,000 (or an unlimited increase if the Proforma Secured Net Secured Leverage Ratio is less than 1.75x). The proceeds of the Credit Facility will be used to pay the Company's unsecured notes which expire in December 2019, and to provide working capital and funds for general corporate purposes. Debt issuance costs related to the Credit Facility amendment totaled $1,507 while those related to the Term Loan A totaled $700, for a combined $2,207 in debt issuance costs. These costs, along with the remaining debt issuance costs from the February 2018 credit facility amendment, will be amortized over the life of the underlying debt instruments and are included in the Other assets classification in the Condensed Consolidated Balance Sheets. The Company may elect to add certain foreign subsidiaries as additional borrowers under the Credit Facility, subject to the satisfaction of certain conditions.

TheOn July 11, 2019, the Company entered into forward-starting interest rate swaps to effectively hedge the cash flow exposure associated with the Company's Term Loan A will be drawn in December 2019. These funds will be used to payvariable-rate borrowings. See Note 8 - Fair Value Measurement for the unsecured notes maturing at that time. The Company will incur a ticking fee of 20 basis points beginning 30 days after the facility begins. The estimated amount of ticking fees to be incurred from June 2019 through the draw date in December 2019 is $150.further information.

The Company amended itshas an accounts receivable securitization facility that provides up to $150,000 based on available collateral and expires in February 2021. Pursuant to the terms of the facility, the Company is permitted to sell certain of its domestic trade receivables on a continuous basis to its wholly-owned, bankruptcy-remote subsidiary, Cooper Receivables LLC (“CRLLC”). In turn, CRLLC may sell from time to time an undivided ownership interest in the purchased trade receivables, without recourse, to a PNC Bank administered, asset-backed commercial paper conduit. The accounts receivable securitization facility has no significant financial covenants until available credit is less than specified amounts.

At June 30, 2020, $169,000 of the available Credit Facility and $70,000 of the accounts receivable securitization facility were drawn to provide funds for working capital and general corporate purposes. The Company had no0 borrowings under the revolving credit facility or the accounts receivable securitization facility at June 30, 2019 or December 31, 2018, other than amounts used to secure letters of credit.2019. Amounts used to secure letters of credit totaled $16,800$21,490 at June 30, 20192020 and $21,651 at December 31, 2018.2019. The Company’s additional borrowing capacity, net of borrowings and amounts used to back letters of credit, and based on eligible collateral through use of its credit facilityCredit Facility with its bank group and its accounts receivable securitization facility at June 30, 2019,2020, was $807,900, including the capacity of the Term Loan A.$337,610.

The Company’s consolidated operations in Asia have renewable unsecured credit lines that provide up to $47,100$62,682 of borrowings and do not contain financial covenants. The additional borrowing capacity on the Asian credit lines, based on eligible collateral and the short-term notes payable, totaled $27,400$56,937 at June 30, 2019.2020.

In addition, atThe Company’s revolving credit facilities contain restrictive covenants which limit or preclude certain actions based upon the measurement of certain financial covenant metrics. However, the covenants are structured such that the Company expects to have sufficient flexibility to conduct its operations. The Company was in compliance with all of its debt covenants as of June 30, 2019 and December 31, 2018, the Company had short-term notes payable of $19,656 and $15,288, respectively, due within twelve months, consisting of funds borrowed by the Company’s operations in the PRC. The weighted average interest rate of the short-term notes payable at June 30, 2019 and December 31, 2018 was 4.76 percent and 4.82 percent, respectively.2020.

Derivative financial instruments are utilized by the Company to reduce foreign currency exchange risks. The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities. The Company does not enter into financial instruments for trading or speculative purposes. The derivative financial instruments include non-designated and cash flow hedges of foreign currency exposures. The change in values of the non-designated foreign currency hedges offset the exchange rate fluctuations related to assets and liabilities recorded on the condensed consolidated balance sheets.Condensed Consolidated Balance Sheets. The cash flow hedges offset exchange rate fluctuations on the foreign currency-denominated intercompany loans and forecasted cash flows. The Company presently hedges exposures in various currencies, generally for transactions expected to occur within the next 12 months. Additionally, the Company utilizes cash flow hedges that hedge already recognized intercompany loans with maturities of up to threetwo years. The notional amount of these foreign currency derivative instruments at June 30, 20192020 and December 31, 20182019 was $181,319$145,498 and $129,542,$167,915, respectively. The counterparties to each of these agreements are major commercial banks.

Foreign currency forward contracts are also used to hedge variable cash flows associated with forecasted sales and purchases denominated in currencies that are not the functional currency of certain entities. The forward contracts have maturities of less than twelve months pursuant to the Company’s policies and hedging practices. These forward contracts meet the criteria for and have been designated as cash flow hedges. Accordingly, the effective portion of the change in fair value of such forward contracts ($(1,821)of $747 and $713$(1,033) as of June 30, 20192020 and December 31, 2018, respectively)2019, respectively, are recorded as a separate component of stockholders’ equity in the accompanying Condensed Consolidated Balance Sheets and reclassified into earnings as the hedged transactions occur.

The Company has categorized its financial instruments, based on the priority of the inputs to the valuation technique, into the three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure the financial instruments fall within the different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

Financial assets and liabilities recorded on the Condensed Consolidated Balance Sheets are categorized based on the inputs to the valuation techniques as follows:

Level 1. Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.

Level 2. Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following.

Level 3. Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.

The valuation of foreign currency derivative instruments was determined using widely accepted valuation techniques. This analysis reflected the contractual terms of the derivatives, including the period to maturity, and used observable market-based inputs, including forward points. The Company incorporated credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. Although the Company determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as current credit ratings, to evaluate the likelihood of default by itself and its counterparties. However, as of June 30, 20192020 and December 31, 2018,2019, the Company assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and determined that the credit valuation adjustments were not significant to the overall valuation of its derivatives. As a result, the Company determined that its derivative valuations in their entirety were to be classified in Level 2 of the fair value hierarchy.